Financial Statements — ASND
Balance Sheet
(in billions EUR)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 0.54 | 0.49 | 0.52 | 0.63 | 0.26 | 0.32 | 0.44 | 0.39 | 0.50 | 0.61 | 0.67 | 0.76 | 0.69 | 0.38 | 0.50 |
| Inventory | 0.30 | 0.30 | 0.29 | 0.27 | 0.25 | 0.23 | 0.19 | 0.17 | 0.15 | 0.10 | 0.10 | 0.09 | 0.06 | -- | -- |
| Total Current Assets | 1.02 | 0.95 | 0.92 | 0.97 | 0.63 | 0.66 | 0.73 | 0.68 | 0.81 | 1.08 | 1.11 | 1.12 | 0.96 | 0.58 | 0.69 |
| Total Non-current Assets | 0.14 | 0.13 | 0.14 | 0.12 | 0.13 | 0.14 | 0.14 | 0.15 | 0.16 | 0.19 | 0.21 | 0.26 | 0.25 | 0.27 | 0.28 |
| Total Assets | 1.15 | 1.09 | 1.06 | 1.09 | 0.76 | 0.80 | 0.87 | 0.82 | 0.97 | 1.27 | 1.33 | 1.38 | 1.21 | 0.85 | 0.97 |
| Total Current Liabilities | 0.99 | 0.94 | 0.89 | 0.84 | 0.85 | 0.80 | 0.21 | 0.19 | 0.20 | 0.14 | 0.12 | 0.10 | 0.12 | 0.07 | 0.07 |
| Total Non-current Liabilities | 0.34 | 0.34 | 0.37 | 0.35 | 0.23 | 0.24 | 0.73 | 0.57 | 0.60 | 0.68 | 0.60 | 0.61 | 0.10 | 0.09 | 0.09 |
| Total Liabilities | 1.33 | 1.28 | 1.25 | 1.19 | 1.08 | 1.04 | 0.95 | 0.76 | 0.80 | 0.82 | 0.72 | 0.70 | 0.21 | 0.16 | 0.16 |
| Total Stockholder Equity | (0.17) | (0.19) | (0.19) | (0.10) | (0.32) | (0.24) | (0.07) | 0.06 | 0.17 | 0.45 | 0.61 | 0.67 | 0.99 | 0.69 | 0.80 |
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Total Revenue | 213.63 | 158.04 | 100.95 | 57.83 | 36.00 | 95.89 | 48.03 | 47.39 | 33.59 | 15.29 | 6.16 | 6.83 | 1.11 | 1.02 | 0.75 |
| Cost of Revenue* | 22.35 | 31.45 | 17.52 | 11.20 | 11.47 | 7.57 | 7.39 | 12.93 | 4.62 | 1.69 | 1.09 | 4.25 | -- | -- | -- |
| Gross Profit | 191.28 | 126.60 | 83.44 | 46.63 | 24.53 | 88.33 | 40.65 | 34.46 | 28.97 | 13.60 | 5.07 | 2.58 | -- | -- | -- |
| Research & Development | 66.88 | 71.99 | 86.60 | 73.54 | 83.48 | 70.69 | 111.44 | 105.02 | 106.11 | 97.43 | 90.38 | 83.19 | 58.76 | 83.31 | 88.15 |
| Selling, General & Admin | 113.40 | 107.56 | 101.05 | 69.83 | 74.31 | 66.78 | 63.61 | 70.28 | 66.54 | 60.67 | 56.58 | 47.42 | 39.28 | 35.35 | 37.25 |
| Total Operating Expenses* | 180.28 | 179.55 | 187.65 | 143.38 | 157.79 | 137.47 | 175.05 | 175.30 | 172.65 | 158.10 | 146.97 | 130.61 | -- | -- | -- |
| Operating Income | 11.00 | (52.95) | (104.21) | (96.74) | (133.26) | (49.14) | (134.41) | (140.84) | (143.68) | (144.50) | (141.89) | (128.03) | (96.93) | (117.63) | (124.65) |
| Pretax Income | (57.37) | (35.01) | (93.56) | (98.18) | (109.15) | (128.53) | (161.58) | (121.86) | (109.62) | (169.12) | (81.37) | (125.26) | (80.34) | (134.44) | (62.98) |
| Tax Provision | 3.62 | 3.85 | 1.06 | 1.02 | 0.23 | 2.51 | 0.65 | (0.43) | 1.30 | (0.17) | (0.05) | 0.24 | 0.01 | (0.07) | (0.19) |
| Net Income | (60.99) | (38.85) | (94.63) | (99.20) | (109.38) | (131.03) | (162.22) | (121.43) | (110.91) | (168.95) | (81.32) | (125.50) | (80.35) | (134.37) | (62.79) |
| Basic EPS | (1.00) | (0.64) | (1.58) | (1.72) | (1.91) | (2.30) | (2.88) | (2.16) | -- | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | (1.58) | (1.72) | (1.91) | (2.30) | (2.88) | (2.16) | -- | -- | -- | -- | -- | -- | -- |
* Derived from reported values
Cash Flow Statement
(in millions EUR)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Operating Cash Flow | (19.50) | (21.65) | (14.31) | (219.02) | (162.89) | (101.58) | (424.89) | (300.17) | (147.04) | (354.01) | (255.18) | (130.79) | (294.34) | (196.82) | (81.62) |
| Investing Cash Flow | (5.09) | (5.04) | (0.70) | 7.26 | 7.76 | 7.16 | 279.82 | 257.60 | 210.65 | 62.53 | 48.43 | 38.54 | 1.34 | (19.08) | (30.12) |
| Financing Cash Flow | 27.81 | (11.04) | (18.02) | 443.84 | 15.97 | 18.42 | 140.35 | (3.01) | (0.70) | 395.42 | 395.50 | 397.74 | 372.02 | 1.41 | 0.02 |
